The medical world is wide open-mouthed at an iPhone app called Ogler Eyescan. Not only because the application can quickly detect eye diseases and conditions, but also because of the fact that it was developed by an 11-year-old girl.
India’s 11-year-old Leena Rafeeq is not only the brains behind Ogle Eyescan, but also the person who managed to develop the iPhone app itself. Spicy pot of bizarre, if you ask OMT editor-in-chief Mark Hofman.
Revolutionary iPhone app by 11-year-old
Times are changing. When I was 11 years old, I was still eating away trays of clay in kindergarten (slow learner), where anno 2023 someone of 11 is shaking up the medical world. Leena Rafeeq is the brains behind the iPhone app Ogler Eyescan and knows how to tackle a tough medical issue.
At the age of 10, Leena threw aside the Harry Potter books and dove deep into the world of ophthalmology. She learned about various diseases and the technology needed to bring to life the vision she had even then.
Without third-party help, she crawled behind her computer and decided to develop the iPhone app herself. The result is Ogler Eyescan: a medical app that can detect eye diseases and conditions through the smartphone’s camera system.
These include white ring, eye melanoma, Pterygium and cataracts. The medical world is watching with open eyes and seeing what technology can bring to healthcare, thanks to an 11-year-old girl.
Leena (Image: Leena Rafeeq / LinkedIn)
It runs in the family
The story is unique, but within the Rafeeq family, Leena is not the first to achieve such achievements. Her younger sister Hana (9), for example, is also a very talented developer who already received recognition from Apple CEO Tim Cook last year.
Of course, that doesn’t make Leena’s achievement any less impressive. The 11-year-old developer is an inspiration to people all over the world. Leena is homeschooled and has the knowledge about developing from her parents, both of whom are Fintech entrepreneurs.
While the iPhone app Ogler Eyescan is already quite an accomplishment in itself, I can hardly help but think that this is just the beginning of Leena’s impact on healthcare. What a little boss.
